Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.
Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...
Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...
A flu shot can still protect you from getting sick with influenza even if you don’t get the vaccination until later in the season.
The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with ...
Dr Reddy's shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay ...
Ladies and gentlemen, good day and welcome to the Quarter Three FY 2025 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participant lines will be in the listen-only ...
THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...
While semaglutide is still on the shortage list ... My hope would be that the manufacturers are also looking at that patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback